AQP5 and central nervous system cancer: The results showed that AQP5 expression in lower grade glioma (LGG), LUAD, and SKCM was significantly different for the OS of patients (Figures 8B–D), and in LGG, SKCM, and UCEC, it was significantly different for the disease-specific survival (DSS) of patients (Figures 8E–G).